Outset Medical (OM) Stock Forecast, Price Target & Predictions
OM Stock Forecast
Outset Medical stock forecast is as follows: an average price target of $3.00 (represents a 147.93% upside from OM’s last price of $1.21) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
OM Price Target
The average price target for Outset Medical (OM) is $3.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $3.00. This represents a potential 147.93% upside from OM's last price of $1.21.
OM Analyst Ratings
According to 9 Wall Street analysts, Outset Medical's rating consensus is 'Buy'. The analyst rating breakdown for OM stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 3 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Outset Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 08, 2024 | Shagun Singh | RBC Capital | $3.00 | $3.40 | -11.76% | 147.93% |
| Jun 21, 2024 | Shagun Singh | RBC Capital | $6.00 | $3.58 | 67.36% | 395.87% |
| Apr 17, 2024 | Rick Wise | Stifel Nicolaus | $6.00 | $2.27 | 164.32% | 395.87% |
| Apr 08, 2024 | Maria Thibault | BTIG | $6.00 | $2.05 | 192.68% | 395.87% |
| Apr 05, 2024 | Kristen Stewart | C.L. King | $6.00 | $1.94 | 209.28% | 395.87% |
| Nov 11, 2022 | RBC Capital | $23.00 | $17.51 | 31.35% | 1800.83% | |
| Aug 03, 2022 | Goldman Sachs | $34.00 | $19.45 | 74.76% | 2709.92% | |
| Jul 18, 2022 | Stifel Nicolaus | $24.00 | $16.91 | 41.89% | 1883.47% | |
| Jun 14, 2022 | Stifel Nicolaus | $30.00 | $20.41 | 46.99% | 2379.34% |
The latest Outset Medical stock forecast, released on Aug 08, 2024 by Shagun Singh from RBC Capital, set a price target of $3.00, which represents a -11.76% decrease from the stock price at the time of the forecast ($3.40), and a 147.93% increase from OM last price ($1.21).
Outset Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 5 |
| Avg Price Target | - | - | $5.40 |
| Last Closing Price | $1.21 | $1.21 | $1.21 |
| Upside/Downside | -100.00% | -100.00% | 346.28% |
In the current month, the average price target of Outset Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Outset Medical's last price of $1.21. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 08, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Aug 08, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
| Jun 21, 2024 | RBC Capital | Sector Perform | Outperform | Upgrade |
| Apr 08, 2024 | BTIG | Buy | Initialise | |
| Aug 17, 2023 | UBS | Neutral | Initialise | |
| Aug 17, 2023 | RBC Capital | Outperform | Sector Perform | Initialise |
| Aug 17, 2023 | BMO Capital | Outperform | Initialise | |
| Aug 17, 2023 | Jefferies | Buy | Initialise | |
| Aug 17, 2023 | Morgan Stanley | Equal-Weight | Initialise | |
| Aug 17, 2023 | Piper Sandler | Overweight | Initialise | |
| Nov 11, 2022 | RBC Capital | Outperform | Initialise | |
| Aug 03, 2022 | Goldman Sachs | Buy | Buy | Hold |
Outset Medical's last stock rating was published by Cowen & Co. on Aug 08, 2024. The company gave OM a "Buy" rating, the same as its previous rate.
Outset Medical Financial Forecast
Outset Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $30.36M | $36.04M | $33.47M | $32.01M | $27.76M | $25.06M | $30.55M | $28.15M | $26.32M | $25.22M | $22.92M | $17.25M | $13.76M |
| Avg Forecast | $43.11M | $39.48M | $37.56M | $35.25M | $33.29M | $31.86M | $30.59M | $29.59M | $27.86M | $26.84M | $31.17M | $30.35M | $30.50M | $30.39M | $34.79M | $31.75M | $30.92M | $25.22M | $27.50M | $30.11M | $26.43M | $25.13M | $23.73M | $21.45M | $13.76M | $11.53M |
| High Forecast | $44.73M | $40.96M | $38.97M | $36.57M | $34.54M | $33.05M | $31.74M | $30.05M | $27.94M | $27.82M | $31.17M | $30.35M | $30.62M | $30.40M | $36.10M | $32.94M | $32.08M | $25.22M | $27.50M | $30.11M | $26.43M | $25.13M | $23.73M | $21.45M | $13.76M | $11.53M |
| Low Forecast | $42.01M | $38.47M | $36.60M | $34.35M | $32.44M | $31.05M | $29.81M | $29.11M | $27.77M | $25.86M | $31.17M | $30.35M | $30.40M | $30.35M | $33.91M | $30.94M | $30.13M | $25.22M | $27.50M | $30.11M | $26.43M | $25.13M | $23.73M | $21.45M | $13.76M | $11.53M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.04% | 1.05% | 1.04% | 1.10% | 0.91% | 1.01% | 1.07% | 1.05% | 1.06% | 1.07% | 1.25% | 1.19% |
Outset Medical's average Quarter revenue forecast for Dec 23 based on 3 analysts is $30.50M, with a low forecast of $30.40M, and a high forecast of $30.62M. OM's average Quarter revenue forecast represents a 0.45% increase compared to the company's last Quarter revenue of $30.36M (Sep 23).
Outset Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-45.45M | $-43.48M | $-40.84M | $-37.92M | $-40.19M | $-43.26M | $-35.09M | $-40.68M | $-28.73M | $-28.43M | $-28.32M | $-29.68M | $-41.43M |
| Avg Forecast | $-43.11M | $-39.48M | $-37.56M | $-35.25M | $-33.29M | $-31.86M | $-30.59M | $-29.59M | $-27.86M | $-26.84M | $-31.17M | $-38.92M | $-30.50M | $-30.39M | $-34.79M | $-35.39M | $-42.59M | $-25.22M | $-27.50M | $-32.17M | $-26.43M | $-25.13M | $-23.73M | $-31.86M | $-13.76M | $-38.62M |
| High Forecast | $-42.01M | $-38.47M | $-36.60M | $-34.35M | $-32.44M | $-31.05M | $-29.81M | $-29.11M | $-27.77M | $-25.86M | $-31.17M | $-31.14M | $-30.40M | $-30.35M | $-33.91M | $-28.31M | $-34.07M | $-25.22M | $-27.50M | $-25.73M | $-26.43M | $-25.13M | $-23.73M | $-25.49M | $-13.76M | $-30.90M |
| Low Forecast | $-44.73M | $-40.96M | $-38.97M | $-36.57M | $-34.54M | $-33.05M | $-31.74M | $-30.05M | $-27.94M | $-27.82M | $-31.17M | $-46.71M | $-30.62M | $-30.40M | $-36.10M | $-42.46M | $-51.10M | $-25.22M | $-27.50M | $-38.60M | $-26.43M | $-25.13M | $-23.73M | $-38.23M | $-13.76M | $-46.35M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.50% | 1.25% | 1.15% | 0.89% | 1.59% | 1.57% | 1.09% | 1.54% | 1.14% | 1.20% | 0.89% | 2.16% | 1.07% |
undefined analysts predict OM's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Outset Medical's previous annual EBITDA (undefined) of $NaN.
Outset Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-46.18M | $-44.05M | $-43.97M | $-41.44M | $-40.78M | $-43.84M | $-36.89M | $-41.23M | $-30.47M | $-30.21M | $-30.02M | $-32.04M | $-42.29M |
| Avg Forecast | $-12.65M | $-13.84M | $-15.03M | $-15.94M | $-17.73M | $-17.90M | $-19.23M | $-20.04M | $-21.94M | $-22.22M | $-22.54M | $-40.92M | $-32.32M | $-35.50M | $-38.13M | $-37.20M | $-43.17M | $-38.70M | $-33.00M | $-33.82M | $-36.83M | $-36.98M | $-35.62M | $-33.78M | $-34.45M | $-39.43M |
| High Forecast | $-12.23M | $-13.38M | $-14.54M | $-15.41M | $-17.14M | $-17.31M | $-18.60M | $-19.37M | $-21.21M | $-21.48M | $-21.79M | $-32.74M | $-29.14M | $-30.20M | $-36.86M | $-29.76M | $-34.54M | $-38.70M | $-33.00M | $-27.05M | $-36.83M | $-36.98M | $-35.62M | $-27.02M | $-34.45M | $-31.54M |
| Low Forecast | $-13.26M | $-14.52M | $-15.77M | $-16.72M | $-18.59M | $-18.78M | $-20.17M | $-21.01M | $-23.01M | $-23.30M | $-23.63M | $-49.10M | $-34.97M | $-38.14M | $-39.99M | $-44.64M | $-51.80M | $-38.70M | $-33.00M | $-40.58M | $-36.83M | $-36.98M | $-35.62M | $-40.53M | $-34.45M | $-47.31M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30% | 1.16% | 1.18% | 0.96% | 1.05% | 1.33% | 1.09% | 1.12% | 0.82% | 0.85% | 0.89% | 0.93% | 1.07% |
Outset Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OM's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Outset Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $36.53M | $36.27M | $36.12M | $33.65M | $32.28M | $33.98M | $30.09M | $32.71M | $23.36M | $22.93M | $22.39M | $24.25M | $26.43M |
| Avg Forecast | $57.33M | $52.50M | $49.94M | $46.87M | $44.27M | $42.37M | $40.68M | $39.34M | $37.05M | $35.69M | $41.45M | $40.36M | $40.56M | $40.41M | $46.27M | $30.34M | $41.11M | $33.54M | $36.56M | $27.58M | $35.14M | $33.41M | $31.55M | $28.52M | $18.30M | $15.34M |
| High Forecast | $59.48M | $54.46M | $51.81M | $48.63M | $45.93M | $43.95M | $42.20M | $39.96M | $37.15M | $36.99M | $41.45M | $40.36M | $40.72M | $40.43M | $48.00M | $36.40M | $42.66M | $33.54M | $36.56M | $33.09M | $35.14M | $33.41M | $31.55M | $28.52M | $18.30M | $15.34M |
| Low Forecast | $55.86M | $51.16M | $48.67M | $45.68M | $43.14M | $41.28M | $39.64M | $38.71M | $36.93M | $34.38M | $41.45M | $40.36M | $40.42M | $40.36M | $45.09M | $24.27M | $40.07M | $33.54M | $36.56M | $22.06M | $35.14M | $33.41M | $31.55M | $28.52M | $18.30M | $15.34M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.78% | 1.19% | 0.82% | 0.96% | 0.93% | 1.09% | 0.93% | 0.70% | 0.73% | 0.79% | 1.33% | 1.72% |
Outset Medical's average Quarter SG&A projection for Dec 23 is $40.56M, based on 3 Wall Street analysts, with a range of $40.42M to $40.72M. The forecast indicates a 11.01% rise compared to OM last annual SG&A of $36.53M (Sep 23).
Outset Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.93 | $-0.90 | $-0.90 | $-0.86 | $-0.85 | $-0.92 | $-0.78 | $-0.87 | $-0.65 | $-0.66 | $-0.70 | $-0.75 | $-3.44 |
| Avg Forecast | $-0.25 | $-0.27 | $-0.30 | $-0.32 | $-0.35 | $-0.35 | $-0.38 | $-0.40 | $-0.43 | $-0.44 | $-0.45 | $-0.55 | $-0.64 | $-0.70 | $-0.76 | $-0.73 | $-0.79 | $-0.75 | $-0.64 | $-0.68 | $-0.71 | $-0.71 | $-0.69 | $-0.80 | $-0.66 | $-2.27 |
| High Forecast | $-0.24 | $-0.27 | $-0.29 | $-0.31 | $-0.34 | $-0.34 | $-0.37 | $-0.38 | $-0.42 | $-0.43 | $-0.43 | $-0.53 | $-0.58 | $-0.60 | $-0.73 | $-0.71 | $-0.76 | $-0.75 | $-0.64 | $-0.68 | $-0.71 | $-0.71 | $-0.69 | $-0.80 | $-0.66 | $-2.27 |
| Low Forecast | $-0.26 | $-0.29 | $-0.31 | $-0.33 | $-0.37 | $-0.37 | $-0.40 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.58 | $-0.69 | $-0.76 | $-0.79 | $-0.77 | $-0.82 | $-0.75 | $-0.64 | $-0.68 | $-0.71 | $-0.71 | $-0.69 | $-0.80 | $-0.66 | $-2.27 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.32% | 1.19% | 1.23% | 1.09% | 1.14% | 1.45% | 1.14% | 1.23% | 0.91% | 0.96% | 0.87% | 1.13% | 1.51% |
According to undefined Wall Street analysts, Outset Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OM previous annual EPS of $NaN (undefined).
Outset Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| OM | Outset Medical | $1.01 | $3.00 | 197.03% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| NVRO | Nevro | $4.05 | $5.84 | 44.20% | Hold |
| CNMD | CONMED | $71.23 | $97.00 | 36.18% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| SIBN | SI-BONE | $13.84 | $18.50 | 33.67% | Buy |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| INSP | Inspire Medical Systems | $190.71 | $223.17 | 17.02% | Buy |
| NARI | Inari Medical | $56.16 | $64.00 | 13.96% | Buy |
| CVRX | CVRx | $13.16 | $14.25 | 8.28% | Buy |
| CLPT | ClearPoint Neuro | $16.34 | $15.00 | -8.20% | Buy |